Diagnosis of the disease requires the combination of clinical performance, imaging, laboratory testing, and pathology. The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment and management of the treatment plan for the treatment of the disease require individual development, typically including drug therapy, rehabilitation plans, and regular follow-up.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of HL chemotherapy.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.